Pierre Jean Meunier
#115,577
Most Influential Person Now
Pierre Jean Meunier's AcademicInfluence.com Rankings
Pierre Jean Meuniermedical Degrees
Medical
#1654
World Rank
#2017
Historical Rank
Public Health
#223
World Rank
#232
Historical Rank
Epidemiology
#256
World Rank
#273
Historical Rank
Download Badge
Medical Biology
Pierre Jean Meunier's Degrees
- PhD Nutritional Sciences Université Paris Cité
Why Is Pierre Jean Meunier Influential?
(Suggest an Edit or Addition)Pierre Jean Meunier's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Vitamin D3 and calcium to prevent hip fractures in elderly women. (1992) (2875)
- Estimates of optimal vitamin D status (2005) (1942)
- The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. (2004) (1573)
- Prevalence of Vitamin D Insufficiency in an Adult Normal Population (1997) (1566)
- Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. (2001) (1551)
- Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. (1994) (1459)
- Body mass index as a predictor of fracture risk: A meta-analysis (2005) (1439)
- Predictive Value of BMD for Hip and Other Fractures (2005) (1308)
- Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. (2005) (1080)
- Intravenous zoledronic acid in postmenopausal women with low bone mineral density. (2002) (868)
- A pooled analysis of vitamin D dose requirements for fracture prevention. (2012) (760)
- Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis (1999) (739)
- Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women (1994) (696)
- SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSIS (1984) (673)
- Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters. (1990) (589)
- Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. (2000) (577)
- Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. (1997) (508)
- Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. (1993) (494)
- Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. (1997) (425)
- Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. (2000) (374)
- Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial. (2002) (323)
- Reviews and Notes: Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis (1995) (312)
- Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group. (2000) (305)
- Comparison of Trabecular Bone Microarchitecture and Remodeling in Glucocorticoid‐Induced and Postmenopausal Osteoporosis (2001) (294)
- Bone mineral density reflects bone mass but also the degree of mineralization of bone: therapeutic implications. (1997) (294)
- MANAGEMENT OF PAGET’S DISEASE OF BONE (1997) (294)
- Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis (1979) (284)
- Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women (1994) (281)
- The degree of mineralization is a determinant of bone strength: a study on human calcanei. (2004) (280)
- Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. (1996) (271)
- Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration (1996) (264)
- Treatment of osteoporosis with fluoride, calcium, and vitamin D. (1981) (238)
- Mean wall thickness of trabecular bone packets in the human iliac crest: Changes with age (1978) (228)
- Addressing the Musculoskeletal Components of Fracture Risk with Calcium and Vitamin D: A Review of the Evidence (2006) (227)
- Differential Effects of Teriparatide and Alendronate on Bone Remodeling in Postmenopausal Women Assessed by Histomorphometric Parameters (2005) (208)
- Do ultrasound measurements on the os calcis reflect more the bone microarchitecture than the bone mass?: a two-dimensional histomorphometric study. (1995) (204)
- Histomorphometric and μCT Analysis of Bone Biopsies From Postmenopausal Osteoporotic Women Treated With Strontium Ranelate (2007) (199)
- Diagnosis and management of osteoporosis in postmenopausal women: Clinical guidelines (1999) (195)
- Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. (2008) (195)
- Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalacia (1983) (194)
- Quantitative histology of myeloma‐induced bone changes (1982) (191)
- The role of mineralization and organic matrix in the microhardness of bone tissue from controls and osteoporotic patients. (2008) (188)
- Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis (2009) (187)
- Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. (1996) (183)
- Serum bone Gla-protein compared to bone histomorphometry in endocrine diseases. (1985) (182)
- Fluoride Salts are no Better at Preventing New Vertebral Fractures than Calcium-Vitamin D in Postmenopausal Osteoporosis: The FAVOStudy (1998) (179)
- Changes in Bone Remodeling Rate Influence the Degree of Mineralization of Bone (2002) (175)
- The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? (1995) (173)
- Bone histomorphometry in Paget's disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissue. (1980) (169)
- Calcium and vitamin D supplements: effects on calcium metabolism in elderly people. (1987) (166)
- Long‐Term Effects of Intravenous Pamidronate in Fibrous Dysplasia of Bone (1997) (158)
- Skeletal distribution and biochemical parameters of Paget's disease. (1987) (155)
- Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. (2000) (154)
- The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report (2004) (154)
- The mineralization of bone tissue: a forgotten dimension in osteoporosis research (2003) (152)
- Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment. (2004) (151)
- Influence of mature adipocytes on osteoblast proliferation in human primary cocultures. (2000) (146)
- Insulin like growth factor I hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term cultures. (1990) (143)
- Vertebral Fracture Risk Reduction With Strontium Ranelate in Women With Postmenopausal Osteoporosis Is Independent of Baseline Risk Factors (2006) (143)
- Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry. (1986) (139)
- EFFECTS OF DISODIUM DICHLOROMETHYLENE DIPHOSPHONATE ON PAGET'S DISEASE OF BONE (1979) (139)
- Long‐Term Strontium Ranelate Administration in Monkeys Preserves Characteristics of Bone Mineral Crystals and Degree of Mineralization of Bone (2005) (137)
- Effects of bisphosphonates on matrix mineralization. (2002) (127)
- Long-term effects of dichloromethylene diphosphonate (CI2MDP) on skeletal lesions in multiple myeloma. (1982) (126)
- Structural determinants of hip fracture in elderly women: re-analysis of the data from the EPIDOS study (2006) (124)
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases. (1980) (124)
- Skeletal blood flow, iliac histomorphometry, and strontium kinetics in osteoporosis: a relationship between blood flow and corrected apposition rate. (1988) (123)
- Skeletal fluorosis: histomorphometric analysis of bone changes and bone fluoride content in 29 patients. (1989) (119)
- Lumbar bone mineral content measured by dual energy X‐ray absorptiometry in newborns and infants (1992) (118)
- Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review (2003) (117)
- Time sequence of secondary mineralization and microhardness in cortical and cancellous bone from ewes. (2010) (108)
- Long term effects of dichloromethylene diphosphonate in Paget's disease of bone. (1982) (108)
- Treatment of Postmenopausal Women with Osteoporosis or Low Bone Density with Raloxifene (1999) (107)
- Dual Energy X-Ray Absorptiometry Measurement of Bone Mineral Content in Newborns: Validation of the Technique (1992) (107)
- Contribution of raloxifene and calcium and vitamin D3 supplementation to the increase of the degree of mineralization of bone in postmenopausal women. (2003) (107)
- Methodological considerations in measurement of bone mineral content (2003) (102)
- Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study (2004) (102)
- Effects of Alendronate on Bone Quality and Remodeling in Glucocorticoid‐Induced Osteoporosis: A Histomorphometric Analysis of Transiliac Biopsies (2000) (101)
- Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis (1983) (97)
- Serum Estradiol and Sex Hormone‐Binding Globulin and the Risk of Hip Fracture in Elderly Women: The EPIDOS Study (2000) (97)
- Role of polyunsaturated fatty acids in the inhibitory effect of human adipocytes on osteoblastic proliferation. (2002) (92)
- Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up) (1997) (91)
- Influence of strontium on bone mineral density and bone mineral content measurements by dual X-ray absorptiometry. (1999) (90)
- In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization (2010) (90)
- Effects of a New Selective Estrogen Receptor Modulator (MDL 103,323) on Cancellous and Cortical Bone in Ovariectomized Ewes: A Biochemical, Histomorphometric, and Densitometric Study (2001) (89)
- Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. (1999) (88)
- Effects of Oral Alendronate on BMD in Adult Patients With Osteogenesis Imperfecta: A 3‐Year Randomized Placebo‐Controlled Trial (2005) (88)
- Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing's syndrome. (1984) (87)
- Therapeutic strategy in Paget's disease of bone. (1995) (83)
- Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry. (1996) (83)
- Influence of experimental conditions on osteoblast activity in human primary bone cell cultures (1990) (83)
- Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry. (1986) (82)
- Bilateral fractures of femoral neck in patients with moderate renal failure receiving fluoride for spinal osteoporosis. (1983) (82)
- Age-related changes in cancellous bone structure. A two-dimensional study in the transiliac and iliac crest biopsy sites. (1988) (81)
- Impaired osteoblast function in osteoporosis: comparison between calcium balance and dynamic histomorphometry. (1984) (80)
- Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: A biochemical and histomorphometric study (1993) (79)
- Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis. (1987) (77)
- Ultrastructural immunocytochemical localization of endogenous 1,25-dihydroxyvitamin D3 and its receptors in osteoblasts and osteocytes from neonatal mouse and rat calvaria. (1987) (76)
- High-Resolution Computed Tomography for Architectural Characterization of Human Lumbar Cancellous Bone: Relationships with Histomorphometry and Biomechanics (1999) (76)
- In vitro evaluation of dose-effects of ethanol on human osteoblastic cells. (1993) (75)
- Fluoride content in human iliac bone: Results in controls, patients with fluorosis, and osteoporotic patients treated with fluoride (1988) (75)
- Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis (2007) (72)
- Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients. (1985) (71)
- Relationship Between Vitamin D Status and Skin Phototype in General Adult Population (2000) (70)
- Bone histology in adults with aseptic necrosis. Histomorphometric evaluation of iliac biopsies in seventy-seven patients. (1983) (69)
- Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: Comparison with normal postmenopausal women (1990) (69)
- Incidence of hip fractures in osteoporotic women treated with sodium fluoride (1987) (67)
- Fluoride therapy for the vertebral crush fracture syndrome. A status report. (1989) (65)
- Consumption of a high calcium mineral water lowers biochemical indices of bone remodeling in postmenopausal women with low calcium intake (2005) (64)
- Bone Histomorphometry of Transiliac Paired Bone Biopsies After 6 or 12 Months of Treatment With Oral Strontium Ranelate in 387 Osteoporotic Women: Randomized Comparison to Alendronate (2014) (64)
- Influence of fat on ultrasound measurements of the Os calcis (1994) (63)
- Short-term effects of corticosteroids on trabecular bone remodeling in old ewes. (1997) (62)
- Clinical Use of Bone Biopsy (2001) (60)
- Dose effects on ewe bone remodeling of short-term sodium fluoride administration--a histomorphometric and biochemical study. (1991) (60)
- Use of etidronate (EHDP) in Paget's disease of bone. (1980) (59)
- hPTH 1–34 treatment of osteoporosis with added hormone replacement therapy: Biochemical, kinetic and histological responses (1991) (59)
- Calcium-vitamin D3 supplementation is cost-effective in hip fractures prevention. (2003) (59)
- Should we use fluoride to treat osteoporosis? A review. (1984) (59)
- Bone loss after cardiac transplantation: Effects of calcium, calcidiol and monofluorophosphate (1993) (57)
- Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis (2008) (57)
- Influence of estrogen therapy at conventional and high doses on the degree of mineralization of iliac bone tissue: a quantitative microradiographic analysis in postmenopausal women. (2005) (56)
- Treatment of vertebral osteoporosis with disodium monofluorophosphate: Comparison with sodium fluoride (1990) (55)
- Effects of intravenous etidronate and oral corticosteroids in fibrodysplasia ossificans progressiva. (1998) (55)
- Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy. (1981) (55)
- Prevention of hip fractures. (1993) (52)
- Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings. (1992) (51)
- Localization of endogenous osteocalcin in neonatal rat bone and its absence in articular cartilage: Effect of warfarin treatment (2005) (51)
- Evidence for a toxic effect of aluminum on osteoblasts: A histomorphometric study in hemodialysis patients with aplastic bone disease (1988) (50)
- Bone mineral density after renal transplantation in children (1994) (50)
- Effects of ethane-1 hydroxy-1, 1-diphosphonate (5 mg/kg/day dose) on quantitative bone histology in Paget's disease of bone. (1981) (48)
- Mechanical properties of ewe vertebral cancellous bone compared with histomorphometry and high-resolution computed tomography parameters. (1998) (48)
- Expression of PPARγ and β/δ in Human Primary Osteoblastic Cells: Influence of Polyunsaturated Fatty Acids (2005) (48)
- Osteopenia and bone‐remodeling abnormalities in warfarin‐treated lambs (1993) (47)
- Prevention of hip fractures by correcting calcium and vitamin D insufficiencies in elderly people. (1996) (47)
- Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis (2003) (46)
- CHAPTER 66 – Vitamin D Insufficiency in Adults and the Elderly (1997) (46)
- Intravenous zoledronic acid in postmenopausal women with low bone mineral density (2003) (46)
- Fluorotoxic metabolic bone disease: an osteo-renal syndrome caused by excess fluoride ingestion in the tropics. (2006) (46)
- Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies (2003) (45)
- Relationship between compressive properties of human os calcis cancellous bone and microarchitecture assessed from 2D and 3D synchrotron microtomography. (2005) (44)
- Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate. (1987) (44)
- Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients. (1996) (41)
- Fluoride increases rat osteoblast function and population after in vivo administration but not after in vitro exposure. (1993) (40)
- Intermethod variation in bone histomorphometry: comparison between manual and computerized methods applied to iliac bone biopsies. (1985) (40)
- Mean wall thickness and formation periods of trabecular bone packets in idiopathic osteoporosis (2006) (40)
- Vitamin D Round Table (2004) (39)
- Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication. (1985) (39)
- Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate. (2011) (39)
- Lateral dual-photon absorptiometry: a new technique to measure the bone mineral density at the lumbar spine. (1991) (39)
- A mathematical model for fluoride uptake by the skeleton (1993) (38)
- Effects of disodium dichloromethylene diphosphonate (CL2MDP) on Paget's disease of bone. (1980) (37)
- The effects of alendronate on bone turnover and bone quality. (1999) (37)
- Predictive value of BMD for hip and other fractures (Journal of Bone and Mineral Research (2005) 20, (1185-1194)) (2007) (37)
- Effect of multiple intravenous pamidronate courses in Paget's disease of bone. (1999) (36)
- Quality of life and vertebral osteoporosis (1992) (36)
- Histomorphometric Approach of Bone Loss in Men (2001) (36)
- Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate. (1983) (36)
- Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis. (2002) (36)
- Dual-Energy X-Ray Absorptiometry in Small Subjects: Influence of Dual-Energy X-Ray Equipment on Assessment of Mineralization and Body Composition in Newborn Piglets (1999) (35)
- Ethical guidelines for publication of research (1989) (34)
- Fortnightly Review: Paget's disease of bone: diagnosis and management (1996) (34)
- Automatic-interactive measurement of resorption cavities in transiliac bone biopsies and correlation with deoxypyridinoline. (1995) (34)
- Is steroid-induced osteoporosis preventable? (1993) (34)
- Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry. (1987) (32)
- Periodic courses of human 1–34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis (1987) (31)
- The use of different dual X-ray absorptiometry brands in a multicenter clinical trial: consequences and limits. (1999) (31)
- Treatment of type 1 Gaucher's disease affecting bone with aminohydroxypropylidene bisphosphonate (pamidronate). (1991) (30)
- Strontium (Sr) distribution and interreactions with bone mineral in male monkey iliac bone after strontium salt (S12911) administration (2006) (30)
- Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids. (2005) (29)
- Amount of bone in osteoporosis and physiological senile osteopenia. Comparison of two histomorphometric parameters (1978) (28)
- Is vitamin K deficiency a risk factor for osteoporosis in Crohn's disease? (2001) (28)
- Fluoride and vertebral fractures (1990) (28)
- Ultrasound measurements on the os calcis in a prospective multicenter study (1994) (28)
- Cross-cultural validation and analysis of responsiveness of the QUALIOST®: QUAlity of Life questionnaire In OSTeoporosis (2005) (27)
- Serum osteocalcin (bone Gla-protein), an index of bone growth in lambs. Comparison with age-related histomorphometric changes. (1991) (26)
- Monitored Impact Loading of the Hip: Initial Testing of a Home-Use Device (2002) (25)
- Evidence for a direct effect of growth hormone on osteoblasts (1993) (25)
- Comparison between bone density and bone strength in glucocorticoid-treated aged ewes. (1995) (25)
- Calcium, Vitamin D and Vitamin K in the Prevention of Fractures due to Osteoporosis (1999) (25)
- Prevention of secondary hyperparathyroidism and hip fracture in elderly women with calcium and vitamin D3 supplements (2005) (25)
- Skeletal fluorosis: Histomorphometric findings (1990) (25)
- Heterogeneity of fracture syndromes in postmenopausal women. (1986) (25)
- Osteogenesis imperfecta: lifelong management is imperative and feasible. (2001) (24)
- Effect of cyclical intravenous pamidronate therapy in children with osteogenesis imperfecta. Open-label study in seven patients. (2002) (24)
- No diffuse osteoporosis in lumbar scoliosis but lower femoral bone density on the convexity. (1996) (24)
- Comparison of bone mass measured by histomorphometry on iliac biopsy and by dual photon absorptiometry of the lumbar spine. (1988) (24)
- In vitro exposure to sodium fluoride does not modify activity or proliferation of human osteoblastic cells in primary cultures (1993) (24)
- [Parathyroid function in Paget's disease of bone]. (1982) (23)
- [Histomorphometric profile of bone fluorosis induced by prolonged ingestion of Vichy Saint-Yorre water. Comparison with bone fluorine levels]. (1986) (23)
- Predictive value of desferrioxamine infusion test for bone aluminium deposits in hemodialyzed patients. (1985) (23)
- Methods for the histological study of femoral neck bone remodelling in patients with fractured neck of femur. (1993) (23)
- Histomorphometric Methods Applied to Bone (1993) (23)
- Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day). (1983) (22)
- Sciatica caused by epidural gas. Four case reports. (2001) (22)
- Fractal Analysis of Bone Texture on Os Calcis Radiographs Compared with Trabecular Microarchitecture Analyzed by Histomorphometry (1998) (22)
- Measurement of Bone Mineral Density in Mother–Daughter Pairs for Evaluating the Family Influence on Bone Mass Acquisition: A GRIO Survey (1998) (22)
- Intersample variation in bone histomorphometry: Comparison between parameter values measured on two contiguous transiliac bone biopsies (1985) (21)
- Strontium ranelate reduces the risk of non vertebral fractures in women with postmenopausal osteoporosis (2003) (21)
- The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women With Postmenopausal Osteoporosis (2004) (21)
- Anabolic agents for treating postmenopausal osteoporosis. (2001) (21)
- INTRAVENOUS ETIDRONATE FOR SPINAL CORD DYSFUNCTION DUE TO PAGET'S DISEASE (1982) (21)
- Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone (2007) (21)
- X‐ray microanalysis of fluoride distribution in microfracture calluses in cancellous iliac bone from osteoporotic patients treated with fluoride and untreated (1991) (20)
- Estimated number of women likely to benefit from bone mineral density measurement in France. (2004) (20)
- Primary bone oxalosis: the roles of oxalate deposits and renal osteodystrophy. (1987) (20)
- [Osteocalcin (or bone gla-protein), a new biological marker for studying bone pathology]. (1986) (20)
- Prevention and treatment of osteoporosis (1995) (20)
- Strontium ranelate reduces the risk of hip fracture in women with postmenopausal osteoporosis (2002) (20)
- A short-term run-in study can significantly contribute to increasing the quality of long-term osteoporosis trials. The strontium ranelate phase 3 program (2002) (19)
- Strontium ranelate as a treatment of vertebral osteoporosis (1997) (19)
- Body composition in children with renal disease: use of dual energy X-ray absorptiometry (1996) (18)
- The effects of long-term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency. (2009) (18)
- Niflumic acid-induced skeletal fluorosis: iatrogenic disease or therapeutic perspective for osteoporosis? (1980) (18)
- Serum aluminium concentration and aluminium deposits in bone in patients receiving haemodialysis (1985) (18)
- Dual-energy X-ray absorptiometry of the spine in anteroposterior and lateral projections (1994) (17)
- Eulerstrut.cavity, a New Histomorphometric Parameter of Connectivity Reflects Bone Strength and Speed of Sound in Trabecular Bone from Human Os Calcis (2007) (17)
- Calcium and Vitamin D are Effective in Preventing Fractures in Elderly People by Reversing Senile Secondary Hyperparathyroidism (1998) (17)
- Vitamin D insufficiency: reappraisal of its definition threshold and bone consequences. (2001) (16)
- Synergistic effect of vitamin D and calcium in preventing proximal femoral fractures in older patients. (2003) (16)
- [Mechanisms of bone loss in osteoporosis]. (1995) (15)
- Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study. (1987) (15)
- Serum aluminium concentration and aluminium deposits in bone in patients receiving haemodialysis. (1985) (15)
- Parathyroid function and vitamin D status in patients with bone metastases of prostatic origin. (1985) (14)
- The kinetics of 99mTc labelled EHDP in paget's disease before and after dichloromethylene-diphosphonate treatment (1981) (14)
- Evaluation and Development of Automatic Two-Dimensional Measurements of Histomorphometric Parameters Reflecting Trabecular Bone Connectivity: Correlations with Dual-Energy X-Ray Absorptiometry and Quantitative Ultrasound in Human Calcaneum (2005) (14)
- Treatment of Paget’s Disease with Etidronate Disodium (1991) (14)
- Bone mineral density of the hip measured with dual-energy X-ray absorptiometry in normal elderly women and in patients with hip fracture (1991) (13)
- Long-term treatment of osteoporosis with 24,25 dihydroxycholecalciferol. (1982) (13)
- Human parathyroid peptide treatment of vertebral osteoporosis (2005) (13)
- [Measurement of bone mineral content by quantitative digital radiography. First results in the lumbar vertebrae]. (1989) (13)
- Oral alendronate induces progressive increases in bone mass of the spine, hip and total body over 3 years in postmenopausal women with osteoporosis (1996) (13)
- INCREASED VERTEBRAL BONE DENSITY IN HEAVY DRINKERS OF MINERAL WATER RICH IN FLUORIDE (1989) (12)
- Is there a relationship between physical activity and dietary calcium intake? A survey in 10,373 young French subjects. (1998) (12)
- Bone histomorphometry and skeletal distribution of Paget's disease of bone. (1994) (12)
- High bone turnover associated with an aluminum-induced impairment of bone mineralization. (1986) (12)
- Osteoporosis: diagnosis and management (1998) (12)
- Influence of food and antacid administration on fluoride bioavailability from enteric-coated sodium fluoride tablets. (1989) (11)
- Immunocytochemical evidence for endogenous calcitonin and parathyroid hormone in osteoblasts from the calvaria of neonatal mice (1985) (11)
- 1 alpha,25-dihydroxyvitamin D3 corrects osteomalacia in hypoparathyroidism and pseudohypoparathyroidism. (1983) (11)
- [Osteoporosis in Klinefelter's syndrome Quantitative bone histological data in 5 cases and relationship with hormonal deficiency (author's transl)]. (1981) (11)
- [Melorheostosis in adults. Apropos of 2 cases, 1 of them treated with diphosphonate (EHDP)]. (1976) (10)
- What is the future for fluoride in the treatment of osteoporosis? (1995) (10)
- Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin (1987) (9)
- [Skeletal distribution and biological markers of Paget's disease]. (1989) (9)
- [Increase of vertebral bone density in heavy drinkers of mineral water with a high fluoride content]. (1989) (8)
- Sapho syndrome with femoral hyperostosis. Two case-reports. (1996) (8)
- [Comparison of the bioavailability of fluoride after the administration of sodium fluoride alone or combined with calcium]. (1988) (8)
- Trabecular thickness, intertrabecular distance and age-related bone loss (1985) (8)
- [Hyperthyroidism and osteoporosis]. (1995) (8)
- Further observations on the treatment of involutional osteoporosis with hPTH 1–34; The effects of added estrogens (1986) (8)
- Strontium ranelate: new efficient anti-osteoporotic agent for treatment of vertebral osteoporosis in postmenopausal women (2002) (7)
- Limit by hypherphosphatemia ofthe usefulness of vitamin D metabolites (1α-hydroxycholecalciferol and 25-hydroxycholecalciferol) in the treatment of renal osteodystrophy (1980) (7)
- Iliac trabecular bone formation predicts radial trabecular bone density changes in type 1 osteoporosis (1991) (7)
- Paget's disease: Treatment results and expectations with present therapies (1999) (6)
- Possible link between changes in plasma 24,25-dihydroxyvitamin D and healing of bone resorption in dialysis osteodystrophy. (1982) (6)
- [Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate]. (1989) (6)
- [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology]. (1975) (6)
- Strontium ranelate : dose-dependent effects in postmenopausal osteoporosis : the STRATOS 2-year randomised trial (2001) (6)
- Calcium-vitamin D supplementation in clinical trials of osteoporosis should be titrated on the basis of pre-study assessments (2002) (5)
- Bone metastases from bronchial carcinoid tumors. Two case-reports. (1999) (5)
- Strontium ranelate: The first anti-osteoporotic agent to reduce the risk of vertebral fracture in patients with lumbar osteopenia (2004) (5)
- Comparison of the acute effects of human and salmon calcitonins in pagetic patients : Relation with plasma calcitonin levels (1980) (5)
- The pagetic lesion (2002) (5)
- [Strontium ranelate: new therapeutic agent for postmenopausal osteoporosis]. (2004) (5)
- [Vitamin D concentrations in blood and skin phototype in a general adult population in France]. (2000) (5)
- Activity Increase After Extraction of Alkaline Phosphatase from Human Osteoblastic Membranes by Nonionic Detergents: Influence of Age and Sex (2000) (5)
- Comparative study of fluoride bioavailability following the administration of sodium fluoride alone and in combination with different calcium salts (1990) (5)
- La maladie osseuse de Paget (2001) (5)
- Fluoride and osteoporosis. (1993) (5)
- Calcitonin and bone diseases (1992) (5)
- Are drugs helpful in adults with osteogenesis imperfecta? (1997) (5)
- The strontium salt S-12911: A new candidate for the treatment of osteoporosis (2006) (5)
- Androgens increase osteoblast-stimulating activity of human breast cancer cells in vitro. (1986) (5)
- [Measurement of lumbar bone mineral density by biphoton absorptiometry. Methodology. Reproductibility. Normal values]. (1987) (5)
- Bone histomorphometry and serum bone gla-protein in the diagnosis of primary hyperparathyroidism (1986) (5)
- [Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)]. (1982) (5)
- [Aluminum poisoning in renal dialysis patients: bone histology. Value of quantitative bone biopsy]. (1984) (5)
- Ultrastructural aspects after cryoultramicrotomy of bone tissue and sutural cartilage in neonatal mice calvaria (1983) (5)
- Spontaneous remission of severe hyperparathyroidism in chronic renal failure. (1983) (5)
- Human Parathyroid Peptide (HPTH 1–34) Treatment Increases the Mean Wall Thickness of Iliac Trabecular Packets of New Bone in Patients with Crush Fracture Osteoporosis (1988) (4)
- 11. Treatment of primary osteoporosis for 1 year with parathyroid peptide hPTH(1–34) by daily injections increases iliac trabecular plate density as well as mean wall thickness of completed packets of new bone (1990) (4)
- Bone histomorphometry in untreated and treated glucocorticoid-induced osteoporosis. (2002) (4)
- Ultrastructural-immunocytochemical localization of endogenous calcitonin in osteoblasts of silicon-treated rats. (1987) (4)
- Effects of two diphosphonates (EHDP and Cl2MDP) on serum uric acid in pagetic patients (2006) (4)
- Patients at high risk of hip fracture benefit from treatment with strontium ranelate (2004) (4)
- [Histomorphometry. Method for evaluating the bone mass]. (1985) (4)
- Renal Osteodystrophy: General Concepts and Current Issues (1984) (4)
- About the Comparison of Two Anabolic Agents, Teriparatide and Strontium Ranelate, in Treated Osteoporotic Women (2009) (4)
- Parathyroid function during treatment with salmon calcitonin. (1980) (4)
- Peripheral and axial measurements of trabecular bone density in patients suspected of idiopathic vertebral osteoporosis. (1983) (4)
- Strontium ranelate : a new effective antiosteoporotic treatment reducing the incidence of vertebral and non vertebral fractures in postmenopausal women with osteoporosis (2003) (4)
- Dialysis Bone Disease in Childhood: Treatment with 25-Hydroxycholecalciferol (1979) (4)
- Bone forming agents (2006) (4)
- A new automatic method for the analysis of 2-D trabecular bone connectivity. (1996) (3)
- Fluoride therapy for the vertebral crush fracture syndrome: A status report (1990) (3)
- [Histomorphometric study of nonpagetic bone in Paget patients. Results before and after diphosphonates]. (1982) (3)
- Dose Variation in the Treatment of Osteoporosis with Synthetic Human Parathyroid Hormone Fragment hPTH 1–34 (1981) (3)
- How do bone resorption inhibitors increase bone mineral density? (1999) (3)
- Ten years of Bone and Asian editorial office opening (1989) (3)
- Advantage of hand bone calcium content measurement by local neutron activation analysis for following up hemodialysis patients. (1983) (3)
- [Phototype, vitamin D status and bone mineral density among women at risk of osteoporosis]. (2006) (3)
- Fluoride and Bone (1996) (3)
- [Lumbar vertebrae mineral content in women. Normal values obtained using quantitative digital radiography]. (1989) (3)
- Nulliparity and Osteoporotic Fracture Risk (2003) (3)
- Fluoride salts for vertebral osteoporosis: The benefit-to-risk ratio depends on the cumulative dose reaching bone (2005) (3)
- Cyrus Cooper, Stephen Gehlbach and Robert Lindsay (eds): Prevention and treatment of osteoporosis: a clinician’s guide (2005) (3)
- Temporal variations in iliac trabecular bone formation in vertebral osteoporosis (2004) (3)
- Oral alendronate increases bone mineral density and reduces vertebral fracture incidence in postmenopausal osteoporosis (1997) (3)
- [Pharmacokinetics of fluorine contained in the Royale Saint-Yorre mineral water]. (1993) (3)
- Prevention of early postmenopausal bone loss with oral tiludronate (2006) (3)
- A new agent containing strontium (S 12911) has a protective effect on bone loss in ovariectomized rats (1992) (2)
- [Resorption and formation in metastatic bone]. (1984) (2)
- [Recurrent puerperal psychosis and calcifications of the basal ganglia. Apropos of a case]. (1991) (2)
- Strontium ranelate reduces the risk of vertebral and non-vertebral fractures in Caucasian women with postmenopausal osteoporosis (2004) (2)
- Risedronate for Paget's disease of bone. (1998) (2)
- Strontium ranelate reduces the risk of vertebral fractures in postmenopausal women with osteopenia (2004) (2)
- Vertebral and non-vertebral anti-fracture efficacy of strontium ranelate in very elderly women with osteoporosis (2005) (2)
- [Is the hypocalcemia test with calcitonin useful in osteoporosis?]. (1983) (2)
- Strontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women whatever the baseline vertebral fractures status (2005) (2)
- [New methods to measure bone quality]. (2004) (2)
- Quantitative bone histology in acute renal failure. (1973) (2)
- [Pyknodysostosis. Morphometric and dynamic analysis of bone in a new case]. (1980) (2)
- Glucocorticoid-induced osteoblastic depression in ewes, a biochemical and histological study (1992) (2)
- Abstract from the Proceedings of the 4th International Workshop on Bone Histomorphometry held at Aarhus, Denmark on June, 1984Iliac bone histomorphometry in skeletal fluorosis (1985) (2)
- [Non-hormonal treatment of postmenopausal osteoporosis]. (1987) (2)
- Microstructural characteristics and remodelling of bone in the neck of femur at the time of fracture (1992) (2)
- [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia]. (1984) (2)
- Bone histomorphometry and bone quality (2009) (2)
- Serum bone gla-protein compared to bone histomorphometry in hemodialyzed patients. (1986) (2)
- Fluoride salts compared to calcium-vitamin D in the treatment of established osteoporosis: The FAVOS study (1996) (2)
- [Osteoporosis at high remodeling and parathyroid function. Histo-biological confrontations (author's transl)]. (1980) (2)
- Online First publication (2003) (2)
- 69 Hypercalcemia of malignancy: Pathogenesis and treatment (1983) (1)
- Comparison between high resolution x-ray computed tomography and bone histomorphometry in ewe trabecular bone (1996) (1)
- Changes following parathyroidectomy in hemodialyzed patients. (1984) (1)
- Rapid and sustained anti-fracture efficacy of strontium ranelate in postmenopausal osteoporosis (2002) (1)
- The relationship between serum vitamin D concentrations andin vivo tetracycline labeling of osteoid in crush fracture osteoporosis (1991) (1)
- Prevention and management of osteoporosis. (2003) (1)
- [Effects of raloxifene on bone loss and fracture risk in the menopausal woman]. (1999) (1)
- Noncarboxylated serum osteocalcin (ncOC) is a predictor of the risk of hip fracture in elderly women (1992) (1)
- Treatment of Acute Osteoporosis Due to Paraplegia with Calcitonin (1982) (1)
- Dose-related bone effects of strontium ranelate in postmenopausal women (2002) (1)
- Intermethod variation in bone histomorphometry (1985) (1)
- [Fluoride poisoning from the Saint-Yorre water with osteomalacia. Apropos of a case with bone histomorphometric analysis]. (1988) (1)
- [Comparison of early bone histomorphometric effects of parathormone and alendronate in osteoporotic women]. (2004) (1)
- Strontium ranelate prevented vertebral fractures in postmenopausal women with osteoporosis (2004) (1)
- Correlation between mean wall thickness of trabecular and cortical bone structure units in human iliac crest (1985) (1)
- Value and limitations of cross-calibration in a multicenter study involving different DXA brands (1993) (1)
- Synergie des effets de la vitamine D et du calcium dans la prévention de la fracture de l'extrémité supérieure du fémur chez les sujets âgésSynergistic effect of vitamin D and calcium in preventing proximal femoral fractures in older patients (2003) (1)
- Treatment of vertebral osteoporosis with fluoride and calcium. (1990) (1)
- Fluoride Therapy for Vertébral Osteoporosis (2006) (1)
- Optimizing patient adherence and persistence in strontium ranelate phase 3 program using a short term run-in study (2002) (1)
- [Effects of 1,25 dihydroxyvitamin d3 on the morphology and alkaline phosphatase activity of ROS 17/2,8 osteoblastic cells: influence of time and dose]. (1990) (1)
- Chronology of the appearance of signs of renal osteo dystrophy a study on acute renal insufficiency (1973) (1)
- Relationship between mechanical properties, histomorphometry and density measurements in trabecular bone from old ewes (1996) (1)
- Calcium and vitamin D (2000) (1)
- [Rheumatic manifestations associated with human immunodeficiency virus infection (HIV)]. (1992) (1)
- Skeletal benefits are maintained through 7 years of alendronate treatment (2002) (1)
- Fluoride salts compared to calcium-vitamin D in the treatment of established postmenopausal osteoporosis: The favos study (2006) (1)
- Deferoxamine for the diagnosis and treatment of aluminum-associated osteodystrophy. (1988) (1)
- Osteoporosis: cause and management (1987) (1)
- Evaluation of the volumetric bone mineral density of the third lumbar vertebral body with a new x ray bone densitometer equipped with a rotating arm (1992) (1)
- Assessment of new non-vertebral osteoporotic fractures during a short-term run-in phase contributes to the internal validation of patient sample size calculations (2002) (1)
- Early effect of strontium ranelate on clinical vertebral fractures in women with postmenopausal osteoporosis (2003) (1)
- Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate. (1984) (1)
- Zoledronic acid safety and efficacy over 5 years in postmenopausal osteoporosis (2006) (1)
- Centralized quality management of bone densitometry for clinical trial and private practice: The use of ISO standard by GECAP (Geneva Quality Assessment Program) (1998) (1)
- The pivotal role of cross-calibration and quality control in an international clinical trial of the strontium salt S-12911 involving multiple DXA brands (2006) (1)
- P27. Variations in gastrointestinal calcium absorption: responsible for heterogeneity of bone remodelling and rates of bone loss in femal type 1 osteoporosis (1994) (1)
- Comparison of the acute effect of eel and salmon calcitonins in pagetic patients. (1982) (1)
- Strontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women without prevalent vertebral fracture (2004) (1)
- Activating effect of non-ionic detergents during the extraction of alkaline phosphatase from human osteoblastic membrane: Influence of age (2006) (0)
- [Use of biochemical markers of bone turnover in Paget's disease of bone]. (2001) (0)
- Strontium ranelate treatment prevents health related quality of life impairement in results from the SOTI study (2002) (0)
- A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis (1986) (0)
- [Paget's bone disease]. (1998) (0)
- [Bone histomorphometry in acute and chronic renal insufficiency. Criteria of definition of osteomalacia]. (1975) (0)
- Observations on the Coupling of Bone Formation and Resorption in Osteoporosis (1982) (0)
- [Comparative study of serum osteocalcin and of the histomorphometric evaluation of iliac biopsy in postmenopausal osteoporosis]. (1984) (0)
- Bone density trends in the distal radius correlate with an index of axial osteoblast depression in osteoporosis (1984) (0)
- [Risk assessment and prevention of fractures of the upper segment of the femur in elderly persons]. (1999) (0)
- [Diagnosis and treatment of osteoporosis]. (1983) (0)
- Supplementation of calcium-vitamin D should be adapted according to the patients status in international phase 3 program on osteoporosis (2002) (0)
- [Relation between urinary cyclic AMP, PTH and histomorphometric resorption parameter. A study of 44 human iliac crest bone biopsies]. (1976) (0)
- Maladie de Paget osseuse. (1998) (0)
- News & views (2005) (0)
- DXA parameters related to internal reference system as predictors of an in vivo variability of BMD measurement from a study on 3808 patients involving 75 centres (1998) (0)
- Abstracts from the symposium on recent advances in Paget’s disease of bone and related bone diseases (1996) (0)
- The Bland and Altman method adapted to quality control of dual-energy X-ray absorptiometry (1998) (0)
- [Primary osteoporosis in the adult]. (1986) (0)
- Bone Blood-Flow and Osteoblast Work Rate in Idiopathic Osteoporosis (1987) (0)
- Prevalence of hypovitaminosis D in the general adult french population (2006) (0)
- Calcitonin and bone diseases. (1992) (0)
- [Bone loss in osteoporotic patients]. (1987) (0)
- [Severity and reversibility of axial bone loss in primary hyperthyroidism: postoperative densitometric follow-up of 10 patients]. (1994) (0)
- The GREES Recommendations for the Registration of New Drugs in the Prevention and Treatment of Osteoporosis (1996) (0)
- [Guidelines for improved therapeutic strategy in patients with Paget's osteitis deformans]. (1996) (0)
- Treatment of Vertebral Osteoporosis with Fluoride Salts (1994) (0)
- [Measurement of lumbar bone density by biphotonic absorptiometry. Contribution of a multidetector system]. (1990) (0)
- [Treatment of postmenopausal osteoporosis with sodium fluoride]. (1983) (0)
- Intersample variations for histomorphometric parameters measured with image analyzers on two contiguous iliac bone biopsies (1985) (0)
- [Desferrioxamine treatment of osteomalacia caused by aluminum poisoning]. (1986) (0)
- Abstracts : international course on osteoporosis: fractures, back pain, disability -management-, June 2-5, 1999, Vienna, Austria (1999) (0)
- Meta-analysis of the effects of inhaled corticosteroids on bone in asthmatic and COPD patients (2002) (0)
- Reduced calcification activity in normal-thickness osteoid in crush fracture osteoporosis: Association with vitamin D status (1987) (0)
- [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)]. (1980) (0)
- Primary hyperparathyroidism in unselected renal stone formers (1987) (0)
- ["Idiopathic osteoporosis" or imperfect osteogenesis]. (1970) (0)
- [Menopause and bone metabolism]. (1984) (0)
- [Osteoporosis at high remodeling and parathyroid function. Histo-biological confrontations (author's transl)]. (1980) (0)
- [Renal insufficiency osteodystrophy studied by biopsy with quantitative reading. Influence of extrarenal and transplantation purifications]. (1969) (0)
- [Corticosteroid-induced osteoporosis]. (1994) (0)
- Relationship between fractal evaluation of bone texture on radiographs and histomorphometric evaluation of trabecular architecture (2006) (0)
- Prospective study of bone status under long term parenteral nutrition (LTPN) (1991) (0)
- 128 LONGITUDINAL LUMBAR BONE MINERAL MEASUREMENTS BY DUAL ENERGY X RAY ABSORPTIOMETRY IN PREMATURE NEWBORNS (1991) (0)
- Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysis. (1979) (0)
- Bone status at the beginning of home parenteral nutrition (HPN) (1992) (0)
- Effects at the basic structure unit level of longterm alendronate treatment in post-menopausal osteoporosis (2006) (0)
- P-87. Changes in Bone Mineral Density and Serum Cholesterol in Osteoporotic Postmenopausal Women Treated with Raloxifene (1998) (0)
- [G.R.I.O. (Research Group on Information on Osteoporosis). Results and perspectives]. (1989) (0)
- Effects of long-term alendronate treatment on bone histomorphometry in postmenopausal osteoporosis (2006) (0)
- [Benefits and risks of fluoride supplements]. (1995) (0)
- Mineralization of Trabecular Osteoid in Osteoporosis: A Comparison between Sr-85 and Tetracycline Kinetics (1983) (0)
- [Diphosphonates in the treatment of hypercalcemia]. (1984) (0)
- [A very mysterious skeleton]. (1998) (0)
- Effects of risedronate on risk of femoral neck and intertrochanteric fractures (2002) (0)
- Bone histomorphometry in long-term studies of alendronate in postmenopausal osteoporosis (2006) (0)
- [Comparison of the bioavailability of fluorine from sodium fluoride alone and in combination with various calcium salts]. (1989) (0)
- [Analgesic effect and fecal blood loss induced by antrafenine. A double-blind comparison with aspirin]. (1981) (0)
- News & views (2005) (0)
- Bone resorption measured on bone biopsies with an automatic analyser correlates with urinary excretion of pyridinoline crosslinks (1992) (0)
- [Treatment of Paget's disease of bone]. (1980) (0)
- [Calcium and vitamin D3, a prevention of femoral neck fractures in elderly women]. (1993) (0)
- 92266449 Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: Increase in volumetric density of iliac cancellons bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone (1993) (0)
- AFPL-67. Zoledronic acid safety and efficacy over 5 years in post-menopausal osteoporosis (2007) (0)
- [Fluorinated osteosis of water and soil origin in a renal insufficiency patient. Apropos of a case with histomorphometric analysis]. (1984) (0)
- [Letter: Onset stages of renal osteodystrophy. Study by quantitative biopsy in acute renal failure]. (1973) (0)
- Incidence of osteoporotic non vertebral fractures coming in the strontium ranelate run-in study could validate sample size calculation (2002) (0)
- [Bone and osteo-articular complications of corticotherapy]. (1990) (0)
- [Antiosteoclastic effect of calcitonin. Effect of a weak dose]. (1981) (0)
- [The treatment of vertebral osteoporosis. Use of sodium fluoride and sodium monofluorophosphate in combination with calcium]. (1990) (0)
- Aluminum-related osteomalacia: Relationship between hyperparathyroidism and osteoid seams width (1985) (0)
- P25. Are there systematic changes in bone formation with time in vertebral osteoporosis (1992) (0)
- Inhaled corticosteroids effects on bone in asthmatic and COPD patients: what is the evidence? (2002) (0)
- 24,25 dihydroxycalciferol: assay in non-anephric patients on chronic haemodialysis and assessment of its possible pathophysiological role in renal osteodystrophy. (1980) (0)
- Optimizing the treatment of Paget's disease of bone. (1997) (0)
- [Physiopathology and prevention of fractures of the proximal end of the femur]. (1995) (0)
- Long-Term Retention and Turnover Studies with 85Sr (1985) (0)
- [Hyrparathyroidism in renal insufficiency treated by hemodialysis and transplantation]. (1970) (0)
- Cortical and Trabecular Bone in the Radius. Their Dynamic Dissimilarity in Osteoporosis and the Close Relationship of Radial Trabecular Bone Trends to Iliac Trabecular Predictors Measured by Dynamic Histomorphometry (1987) (0)
- [Fluorine salts and vertebral osteoporosis. Reexamination of a controversy]. (1992) (0)
- Calcium regulation and bone metabolism : basic clinical aspects : proceedings of the 9th International Conference on Calcium Regulating Hormones and Bone Metabolism, Nice, 25 October-1 November 1986 (1987) (0)
- [Large clinical trials for osteoporosis]. (2003) (0)
- [Intra-nasal calcitonin for the prevention of postmenopausal osteoporosis]. (1992) (0)
- Automatic analysis of 2-D connectivity in iliac trabecular bone from normal women with regard to menopause. (1996) (0)
- BONE expands board and editorial content (1986) (0)
- An Economic Evaluation of Tiludronic Acid Treatment in Paget’s Disease of Bone (1997) (0)
- Bone Loss in Gaucher Disease (1985) (0)
- Strontium ranelate decreases the risk of hip fracture over 3 and 5 years in post menopausal women at high risk (2008) (0)
- [Induced hypocalcaemia test using salmon calcitonin as a means for the evaluation of osteoclastic activity (author's transl)]. (1977) (0)
- Bone Loss in Osteoporosis: Seduced Bone Formation and Increased Resorption Indices both Correlate with Negative Calcium Balance (1983) (0)
- Bone formation and osteoid mineralization in osteoporosis (1984) (0)
- Strontium ranelate antifracture study program : current data (2002) (0)
- Ewe, an animal model for corticosteroid-induced osteoporosis (1996) (0)
- Prevalence of Latent Vitamin D Insufficiency in a Middle-Aged Normal Population from SU. VI. MAX Study (1998) (0)
- [Fluoride osteosis of hydro-telluric origin in a female patient with renal insufficiency. Apropos of a case with histomorphometric analysis]. (1984) (0)
- [The osteoporosis disease in menopausal women. Physiopathology and therapeutic impact]. (1985) (0)
- Relation entre statut en vitamine D et phototype en population générale adulte en France (2001) (0)
- Hypovitaminosis D is the main determinant of secondary hyperparathyroidism which contributes to bone fragility in elderly women with hip fractures and other non vertebral fractures (1992) (0)
This paper list is powered by the following services:
